Flanigan TP - Search Results

1

Buprenorphine for human immunodeficiency virus/hepatitis C virus-coinfected patients: does it serve as a bridge to hepatitis C virus therapy?

Taylor LE, Maynard MA, Friedmann PD, Macleod CJ, Rich JD, Flanigan TP, Sylvestre DL. Taylor LE, et al. Among authors: flanigan tp. J Addict Med. 2012 Sep;6(3):179-85. doi: 10.1097/ADM.0b013e318257377f. J Addict Med. 2012. PMID: 22614935 Free PMC article.

2

Human immunodeficiency virus in correctional facilities: a review.

Spaulding A, Stephenson B, Macalino G, Ruby W, Clarke JG, Flanigan TP. Spaulding A, et al. Among authors: flanigan tp. Clin Infect Dis. 2002 Aug 1;35(3):305-12. doi: 10.1086/341418. Epub 2002 Jul 3. Clin Infect Dis. 2002. PMID: 12115097 Review.

3

The importance of routine HIV testing in the incarcerated population: the Rhode Island experience.

Desai AA, Latta ET, Spaulding A, Rich JD, Flanigan TP. Desai AA, et al. Among authors: flanigan tp. AIDS Educ Prev. 2002 Oct;14(5 Suppl B):45-52. doi: 10.1521/aeap.14.7.45.23867. AIDS Educ Prev. 2002. PMID: 12413192

4

A review of the case for hepatitis B vaccination of high-risk adults.

Rich JD, Ching CG, Lally MA, Gaitanis MM, Schwartzapfel B, Charuvastra A, Beckwith CG, Flanigan TP. Rich JD, et al. Among authors: flanigan tp. Am J Med. 2003 Mar;114(4):316-8. doi: 10.1016/s0002-9343(02)01560-7. Am J Med. 2003. PMID: 12681460 Review.

5

Directly observed therapy (DOT) for individuals with HIV: successes and challenges.

Mitty JA, Macalino G, Taylor L, Harwell JI, Flanigan TP. Mitty JA, et al. Among authors: flanigan tp. MedGenMed. 2003 Feb 4;5(1):30. MedGenMed. 2003. PMID: 12827091 Free article. Review.

6

Development of opportunistic infections after diagnosis of active tuberculosis in HIV-infected patients.

Kwara A, Carter EJ, Rich JD, Flanigan TP. Kwara A, et al. Among authors: flanigan tp. AIDS Patient Care STDS. 2004 Jun;18(6):341-7. doi: 10.1089/1087291041444069. AIDS Patient Care STDS. 2004. PMID: 15294084

7

Apathy correlates with cognitive function but not CD4 status in patients with human immunodeficiency virus.

Paul R, Flanigan TP, Tashima K, Cohen R, Lawrence J, Alt E, Tate D, Ritchie C, Hinkin C. Paul R, et al. Among authors: flanigan tp. J Neuropsychiatry Clin Neurosci. 2005 Winter;17(1):114-8. doi: 10.1176/jnp.17.1.114. J Neuropsychiatry Clin Neurosci. 2005. PMID: 15746491

8

Use of community-based, directly observed therapy for HIV infection: lessons learned for treatment of hepatitis C virus infection.

Flanigan TP, Taylor LE, Mitty JA. Flanigan TP, et al. Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S346-8. doi: 10.1086/427451. Clin Infect Dis. 2005. PMID: 15768346

9

The use of community-based modified directly observed therapy for the treatment of HIV-infected persons.

Mitty JA, Macalino GE, Bazerman LB, Loewenthal HG, Hogan JW, MacLeod CJ, Flanigan TP. Mitty JA, et al. Among authors: flanigan tp. J Acquir Immune Defic Syndr. 2005 Aug 15;39(5):545-50. J Acquir Immune Defic Syndr. 2005. PMID: 16044005

10

A success story: HIV prevention for injection drug users in Rhode Island.

Beckwith CG, Moreira CC, Aboshady HM, Zaller N, Rich JD, Flanigan TP. Beckwith CG, et al. Among authors: flanigan tp. Subst Abuse Treat Prev Policy. 2006 Dec 4;1:34. doi: 10.1186/1747-597X-1-34. Subst Abuse Treat Prev Policy. 2006. PMID: 17144920 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

237 results

Search Page

Filters